A Case of Secondary Sclerosing Cholangitis in Langerhans Cell Histiocytosis.
- Author:
Ja Hyung KIM
1
;
Bo Hwa CHOI
;
Kyung Mo KIM
;
Hyung Nam MOON
Author Information
1. Department of Pediatrics, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Secondary sclerosing cholangitis;
Langerhans cell histiocytosis
- MeSH:
Bile Ducts;
Child;
Child, Preschool;
Cholangitis;
Cholangitis, Sclerosing*;
Cholestasis;
Cystic Fibrosis;
Esophageal and Gastric Varices;
Fibrosis;
Histiocytosis, Langerhans-Cell*;
Humans;
Hypertension, Portal;
Inflammation;
Liver Cirrhosis, Biliary;
Liver Diseases;
Liver Failure;
Liver Transplantation;
Male;
Prognosis
- From:Korean Journal of Pediatric Gastroenterology and Nutrition
2001;4(1):120-124
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Sclerosing cholangitis is a chronic cholestatic disease characterized by inflammation and obliterative fibrosis of the bile ducts, leading to biliary cirrhosis and ultimately to liver failure. In children, sclerosing cholangitis is known to be associated with Langerhans cell histiocytosis, as well as with congenital immunodeficiencies and cystic fibrosis. Secondary sclerosing cholangitis is suspected in Langerhans cell histiocytosis with chronic cholestasis, liver dysfunction and portal hypertension. Unlike primary sclerosing cholangitis, the cholangitis associated Langerhans cell histiocytosis is destructive in nature and progresses more rapidly to biliary cirrhosis, therefore uniformly the prognosis is poor. In this setting, liver transplantation should be considered early in children with sclerosing cholangitis complicating Langerhans cell histiocytosis before end-stage liver failure and variceal bleeding. We experienced a case of secondary sclerosing cholangitis in Langerhans cell histiocytosis in a 2-year-old boy. We report this case with brief review of the related literatures.
